Benzinga | Aug 12, 2021 08:11AM EDT

Corbus Pharmaceuticals Q2 EPS $(0.15) Up From $(0.52) YoY, Sales $137.00K Down From $286.35K YoY

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.15) per share. This is a 71.15 percent increase over losses of $(0.52) per share from the same period last year. The company reported $137.00 thousand in sales this quarter. This is a 52.16 percent decrease over sales of $286.35 thousand the same period last year.